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Abstract: BACKGROUND: While representing only 3-4% of malignant skin tumors, cutaneous melanoma is the most
aggressive and lethal. Statistical knowledge about the biological behavior of this tumor is essential for guiding daily
outpatient practice and aiding public health policies. 
OBJECTIVES: To analyze the profile of patients with cutaneous melanoma attending a pathology department in Teresina
(state of Piauí) between 2000 and 2010. 
METHODS: Retrospective study of melanoma patients diagnosed between 2000 and 2010 in the São Marcos Hospital in
the city of Teresina. The pathology laboratory reports were studied and all the statistical analyses performed using
SPSS 19.0. 
RESULTS: A total of 25 in situ, 199 invasive and 89 metastatic melanomas of unknown primary site were observed.
Histological types found were nodular (52.8%), superficial spreading melanoma (18.6%), acral (10.6%) and lentigo
maligna (9.5%). In 144 (73.4%) cases the Breslow thickness was >1 mm. Metastasis was found in 28.6% of invasive
melanomas and nodular melanoma, Clark IV/ V, Breslow > 1 mm, mitotic index ≥ 6 and ulcerated lesions were more
likely to metastasize. 
CONCLUSION: Most melanomas presented Breslow> 1mm. The main factors associated with metastasis were nodular
type, Clark IV / V, Breslow> 1mm, mitotic index ≥ 6 and ulcerated lesions.
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Resumo: FUNDAMENTOS: Apesar de representar apenas 3-4% dos tumores malignos de pele, o melanoma cutâneo é o
mais agressivo e letal deles. O conhecimento estatístico do comportamento biológico deste tumor em nosso meio
ambiente é fundamental para orientar a prática ambulatorial diária e para auxiliar políticas de saúde pública.
OBJETIVOS: Analisar o perfil de pacientes com melanoma cutâneo diagnosticados em serviço de referência em patolo-
gia em Teresina-Piauí no período de 2000 a 2010. 
MÉTODOS: Estudo retrospectivo de pacientes com melanoma diagnosticados entre 2000 e 2010 no Hospital São Marcos,
Teresina-Piauí-Brasil. Estudou-se laudos histopatológicos e realizou-se análises estatísticas com o programa SPSS 19,0. 
RESULTADOS: Um total de 25 melanomas in situ, 199 invasivos e 89 metastáticos de sítio primário desconhecido foram
observados. Tipos histológicos encontrados foram nodular (52,8%), melanoma extensivo superficial (18,6%), acral
(10,6%) e lentigo maligno (9,5%). Em 144 (73,4%) casos o índice de Breslow foi >1 mm. Verificou-se metástases em
28,6% dos melanomas invasivos e melanoma nodular, Clark IV/V, Breslow >1 mm, índice mitótico ≥6 e lesões ulce-
radas estavam mais propensos a metástases. 
CONCLUSÃO: Melanomas com Breslow >1mm foram os casos predominantes. Principais fatores associados a metásta-
se foram tipo nodular, Clark IV/V, Breslow >1mm, índice mitótico ≥6 e lesões ulceradas.
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INTRODUCTION
Cutaneous melanoma (CM) is an uncommon but
often aggressive form of skin cancer owing to its signif-
icant morbidity and  high mortality rates. Although it
accounts for less than 5% of all skin cancers, most deaths
related to skin cancer are from melanoma.1 The inci-
dence of melanoma is increasing rapidly. Brazil´s
National Cancer Institute (INCA), estimates that
approximately 6,230 new cases of melanoma can be
expected in 2012. Around 1392 people died of the dis-
ease in Brazil in 2009.2
Since all the therapies normally used in advanced
cases, such as chemotherapy, radiotherapy, biochemical
therapy and vaccines, seem to be incapable of providing
cures or improving survival rates, early diagnosis and
therapy remain the main key to managing melanoma.3,4
A diagnosis of melanoma should be suspected in all
melanocytic lesions presenting changes in color, size or
shape. The presence of asymmetry of the lesion, irregu-
lar borders, colour variation and with a diameter over 6
mm are the ABCD diagnosis of melanoma and are
indicative of biopsy for diagnostic confirmation.5
The exact process that leads to the malignant
transformation of melanocytes remains uncertain, but
among the possible etiological factors solar radiation,
particularly ultraviolet light (UV), is one of the more
likely factors. It is believed that UV radiation can cause
direct damage to the DNA.1 Since Teresina is a city locat-
ed at latitude 5º south and 73% of its population refer
sun exposure without protection, skin cancer is without
any doubt a public health problem in our city.6
In south and southeast Brazil, with the highest
estimated melanoma rates, epidemiological studies on
this neoplasm are now more common.1-5,7-19
Epidemiological data on the prevalence and clinical fea-
tures of melanoma nevertheless are in short supply in
the northeast of the country. Considering the size of our
country and the ethnic characteristics of the Brazilian
population, these types of studies are important for bet-
ter understanding the characteristics and behavior of
this disease. Such an approach could facilitate medical
initiatives aimed at identifying cases, as well as boosting
relevant campaigns to draw attention to the disease of
the healthcare community and the population in gener-
al.11,14
The aim of present study was to analyze the epi-
demiological and histopathological data of patients
with cutaneous melanoma attending a reference pathol-
ogy department service in Teresina from 2000 to 2010
and to present statistical data that could be useful as a
basis for epidemiological studies and disease preven-
tion in northeast Brazil. A further aim was to identify
the histopathological factors associated with melanoma
metastasis.
METHODS
A retrospective study was conducted of all
patients who had had a histopathologic diagnosis of
melanoma in a pathology reference laboratory located
in Teresina (Piauí), Brazil, between January 2000 and
December 2010.
The sample was non-probabilistic (convenience
sample), comprising all patients with a histopathologic
diagnosis of melanoma during the period under study.
Cutaneous melanoma located in the mucosa or eyes,
slides review, residual melanomas and relapse
melanomas were excluded. A total of 313 cases of
metastatic or primary cutaneous melanoma were
assessed.
Data collected in protocol by the authors includ-
ed patient characteristics (age, sex, origin, tumor loca-
tion) and melanoma morphology (histological type,
stage of invasion using Clark level and Breslow thick-
ness, radial growth phase, vertical growth phase,
Mitotic index, tumor-infiltrating lymphocytes, regres-
sion, ulceration) and surgical outcomes (clear surgical
margins, analysis of sentinel lymph node and metasta-
sis). Each slide from the 11-year period was evaluated
by one of four pathologists from our dermatology serv-
ice. To classify the subtype of melanoma, we used by
World Health Organization criteria.20
The statistical analyses were performed using
SPSS for Windows, 19.0 (SPSS, Inc., Chicago, Illinois).
Descriptive statistics were reported for all variables. The
correlation between the categorical variables were stud-
ied with the Pearson chi-square test or Fisher’s exact
test. All statistical tests were 2-sided, and we considered
a P value of less than 0.05 to be statistically significant.
Differences between means for continuous variables
were evaluated by one-way analysis of variance
(ANOVA) test.
A logistic regression was also performed using as
a dependent variable the presence of metastases, and as
independent variables gender, age group, site, histolog-
ical type, Breslow thickness, Clark level, tumor-infiltrat-
ing lymphocytes, mitotic index, ulceration and
histopathological regression. As association measure we
used Odds Ratio (OR), considering a confidence inter-
val of 95% (95 CI).
This project was approved by the Research Ethics
Committee of the  São Marcos Hospital, in accordance
with National Health Council Resolution Nº 196/96
guidelines.
RESULTS
A total of 313 patients were included in the analy-
sis: 25 (7.9%) were in situ cutaneous melanoma (CM),
199 (63.6%) were invasive CM and 89 (28.4%) were
metastatic CM. Concerning histological type in the
invasive group, nodular melanoma was found in 105
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cases (52.8%), superficial spreading melanoma in 37
cases (18.6%), acral-lentiginous melanoma in 21 cases
(10.6%) and lentigo maligna melanoma in 19 cases
(9.5%). Other types of CM were found in 5 cases (2.5%)
(Table 1). Graph 1 shows the distribution of cases
according to histological type per year.
The invasive CM group comprised 101 (50.8%)
women and 97 (48.7%) men, a ratio of 1.04 women to
men. Mean age was 70.1 ± 16.3 years. The majority of
the patients were aged over 50 (n = 167, 83.9%) and
lived in rural areas of Piauí (n = 79, 39.7%) (Table 1).
With regard to the topography of lesions, these
were located on the upper limbs (n = 22, 11.1%), lower
limbs (n = 67, 33.7%), trunk (n = 62, 31.2%) and head and
neck (n = 40, 20.1%) (Table 1). The women predominant-
ly presented tumors on the trunk (28.7%), lower limbs
(27.7%) and head/neck (25.7%) while the men had
tumors mainly on their lower limbs (40.2%) and trunk
(34.0%). These differences were statistically significant
(p = 0.038) (Table 1).
A total of 72.4% had a Breslow thickness of over 1
mm. The men presented more cases with a higher
Breslow thickness (78.4% versus 67.3% of women) and
this difference was statistically significant (p = 0.045)
(Table 1). The mean thickness of the primary tumors was
8.8 mm (95 CI = 7.3-10.5). Nodular melanoma had the
highest mean Breslow thickness (12.2 mm; 95 CI = 9.7-
14.8), followed by acral-lentiginous (8.9 mm; 95 CI = 6.2-
11.8)), lentigo maligna (2.7 mm; 95 CI = 0.4-6.9) and
superficial spreading (1.4 mm; 95 CI = 1.0-1.8). This dif-
ference of the average Breslow thickness was statistically
significant with p <0.0001 (one-way ANOVA) (Graph 2).
Among the patients identified with nodular
melanoma, the mean age was 71.3 years and the major-
ity was Clark IV (46.3%) or Clark V (33.7%). Regarding
acral lentiginous melanoma, the mean age was 76.1
years and the Clark V was predominant (52.4%). Of
those who had lentigo maligna melanoma, the mean
age was 65.1 years and the Clark level predominant was
II (76.5%). The superficial spreading melanoma group
had a mean age of 65.3 years and 48.6% were Clark III. 
Of the total sample of invasive CM, there was a
predominance of cases with Clark IV (n = 65, 32.7%) and
V (n = 52, 26.1%) levels (Table 1). Tumor-infiltrating
lymphocytes, ulceration and histopathological regres-
sion were found in 76.9%, 54.8% and 17.1% of the inva-
sive tumors respectively. The mitotic index was ≥ 6
mitoses/HPF (high-power field) in 37.2%. This value
was statistically significantly higher (p = 0.011) in men
(n = 45, 46.4%) than in women (n = 29, 28.7%) (Table 1).
Sentinel lymph node biopsy was performed in 19
cases (9.5% of invasive melanomas). In 9 of these
(47.4%), frozen section examination was undertaken,
showing compromised lymph nodes by neoplasia in 4
cases (44.4%). The result of the histopathological study
revealed 13 cases (68.4%) free of cancer. There was no
discrepancy between the results of the frozen section
procedures and histopathology.
Metastasis was observed in 28.6% (n = 57) of the
patients with invasive CM (Table 2). Considering these
57 cases and 89 cases of metastatic melanoma (a total of
146), the main sites of regional and distant metastases
were lymph nodes (78.1%), skin and subcutaneous
areas (22.6%), lung (6.8%) and liver (4.8%) (Table 3). 
As shown in table 2, nodular melanoma (OR =
4.88; 95 CI =1.61-14.8), Clark IV (OR = 4.12, 95 CI = 1.29-
13.15), Clark V (OR = 5.79, 95 CI = 1.77-18.89), Breslow
> 1 mm (OR = 11.1, 95 CI = 2.57-47.91), mitotic index ≥
6 (OR = 2.57, 95 CI = 1.33-4.98) and ulcerated lesions
(OR = 2.41, 95 CI = 1.21-4.79) were more likely to metas-
tasize. 
DISCUSSION
Cutaneous melanoma (CM) is a serious threat to
public health, and early diagnosis currently remains the
“best therapy” for this type of skin cancer. Unlike in the
United States where, according to the Surveillance,
Epidemiology and End Results (SEER) Program, the
incidence of in situ CM has increased over the past 30
years due to increased attention paid by physicians and
the general population to the early diagnosis of CM, we
observed a low rate of in situ CM (7.9%) in our study.21
This rate was also lower than that found in other sur-
veys performed in south and southeast Brazil, in which
in situ diagnosis is as high as 39% (Table 4).1,3-5,7-19
Brazilian studies tend to disagree regarding the
predominant histological CM type. Although superfi-
cial spreading melanoma is the main diagnosed histo-
logical CM type in the majority of studies,1,3-5,7,8,13,16,19 we
found that majority of cases involved nodular
melanoma (52.8%), as shown in Porto Alegre (RS)10 and
São Paulo (SP)9 in the 1980s (36.6% and 19.8% respec-
tively) and Londrina (PR)11 and Brasília (DF)14 in the
1990s (41.1% and 45.0% respectively).
The predominance of nodular melanoma is
alarming, since the nodular and acral lentiginous histo-
logical types are generally associated with a worse
prognosis - and consequently a greater Breslow thick-
ness.22 We were able to identify nodular melanoma
(12.18 mm) and acral-lentiginous (8.95 mm) with a
higher Breslow thickness mean than lentigo maligna
(2.74 mm) and superficial spreading (1.37 mm) (Graphic
2). In their evaluation of 496 cases Weber et al. also
observed a statistically significant difference between
histological types lentigo maligna melanoma and
superficial spreading melanoma (mean 1.829 mm) and
nodular and acral types (mean 5.035 mm).1
In the analysis of  these results it is important to
keep in mind that these data refer to a pathology refer-
ence laboratory in a tertiary care hospital, where cases
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Total 97 48.7 101 50.8 199* 100.0
Age Group (years) 0.400
≤ 50 12 12.4 10 9.9 22 11.1
> 50 82 84.5 85 84.2 167 83.9
Missing 3 3.1 6 5.9 10 5.0
Origin 0.381
Teresina 28 28.9 31 30.7 59 29.6
Rural area of Piauí 42 43.3 37 36.6 79 39.7
Other state 23 23.7 33 32.7 56 28.1
Missing 4 4.1 0 0.0 5 2.5
Site 0.038
Head and neck 14 14.4 26 25.7 40 20.1
Trunk 33 34.0 29 28.7 62 31.2
Upper Limbs 7 7.2 15 14.9 22 11.1
Lower Limbs 39 40.2 28 27.7 67 33.7
Missing 4 4.1 3 2.9 8 4.0
Histological Type 0.678
Nodular 55 56.7 50 49.5 105 52.8
Lentigo maligna 10 10.3 9 8.9 19 9.5
Superficial spreading 15 15.5 22 21.8 37 18.6
Acral lentiginous 10 10.3 11 10.9 21 10.6
Other 3 3.1 2 2.0 5 2.5
Missing 4 4.1 7 6.9 12 6.0
Breslow 0.045
≤ 1 mm 14 14.4 25 24.8 39 19.6
> 1 mm 76 78.4 68 67.3 144 72.4
Missing 7 7.2 8 7.9 16 8.0
Clark Level 0.461
II 11 11.3 20 19.8 31 15.6
III 18 18.6 16 15.8 34 17.1
IV 35 36.1 30 29.7 65 32.7
V 26 26.8 26 25.7 52 26.1
Missing 7 7.2 9 8.9 17 8.5
Tumor-inﬁltrating lymphocytes 0.299
Absence 17 17.5 14 13.9 31 15.6
Presence 73 75.3 80 79.2 153 76.9
Missing 7 7.2 7 6.9 15 7.5
Mitotic index 0.011
< 6 mitoses/HPF 44 45.4 60 59.4 104 52.3
≥ 6 mitoses/HPF 45 46.4 29 28.7 74 37.2
Missing 8 8.2 12 11.9 21 10.6
Ulceration 0.147
Absence 32 33.0 42 41.6 74 37.2
Presence 57 58.8 52 51.5 109 54.8
Missing 8 8.2 7 6.9 16 8.0
Histopathological regression 0.060
Absence 66 68.0 80 79.2 146 73.4
Presence 21 21.6 13 12.9 34 17.1
Missing 10 10.3 8 7.9 19 9.5
Category
Gender
Male Female
n % n %
Total
n %
p**
TABLE 1: Distribution and features of 199 invasive cutaneous melanomas, according to gender, diagnosed in a 
Pathology reference service in Teresina (Piauí), 2000-2010
* One patient with missing gender data ** Pearson chi-square test or Fisher’s exact test
are likely to have been diagnosed later rather than soo-
ner and involving lesions already growing vertically,
thereby masking possible histopathological findings of
other types of melanoma.4
Late diagnosis was in fact the rule in our study:
only 19.6% showed Breslow thickness <1 mm, the lower
nationwide rate (Table 4),1,3-5,7-19 and the average Breslow
thickness was 8.57 mm. This is of major concern given
that approximately 20% of tumor patients presenting
Breslow 1-4 mm have sentinel lymph node metastases,
with this value increasing to 34% among patients with
an index of over 4mm.23
The identification of the early stages of cancer can
reduce morbidity and mortality. Three levels of preven-
tion exist: primary, which prevents the occurrence of the
disease; secondary, which consists of early diagnosis
through screening;  and tertiary, which prevents defor-
mities, recurrence and death.6
Primary prevention of skin cancer focuses espe-
cially on sun protection, since the relationship between
elevated levels of exposure to ultraviolet light (UV) and
a higher incidence of skin cancer is well established in
the literature. Studies have shown that the damage
caused by UV radiation, particularly on DNA, has a
major role in the development of melanoma, related to
65-90% of cases of tumor. The main target is usually
children, since they are exposed to up to three times
more sunlight than adults and the risk of cancer devel-
opment is often related to cumulative exposure in child-
hood and adolescence.14,24 Secondary prevention is
based on mass detection campaigns to detect skin
tumors at an earlier stage. In Brazil, the Sociedade
Brasileira de Dermatologia (SBD) has since 1999 run the
GRAPH 1: Distribution of invasive cutaneous melanomas diagno-
sed per year in a pathology reference service in Teresina (Piauí),
according to histological type, 2000-2010
GRAPH 2: Error bar representing Breslow thickness mean of nodu-
lar, superfical spreading, acral-lentiginous and lentigo maligna
melanoma diagnosed in a pathology reference service in Teresina
(Piauí), 2000-2010
National Campaign to Prevent Skin Cancer, involving
dermatologists examining and informing the popula-
tion of the risks. Skin cancer screening programs can
provide early diagnosis of melanoma in 90% of cases,
with a significant reduction of mortality.6,24 Knowledge
of CM epidemiology is a vital component for both pri-
mary and secondary public health strategies.3
We observed a gender balance (48.7% male vs.
50.8% female) and prevalence in people over 50 years
(83.9%). Lasithiotakis et al linked men and older people
with a worse prognosis for melanoma.25 Scoggins et al
indicated that the male gender not only had worse
prognosis but also greater incidence.26
Men presented a higher proportion of thicker
Breslow (> 1 mm): 78.4% compared to 67.3% of women,
which was statistically significant. At the Santa Casa
Hospital in São Paulo, women presented a greater pro-
portion (60%) of thinner CM (up to 2.0 mm) and men
presented a greater proportion (74%) of thicker CM (>
2.0 mm).3 Karakousis and Driscoll, in a study of 695
patients with primary melanoma, found 5-year survival
rates of 75% for men versus 89% for women, and also
higher age and thicker lesions among male patients.27
In women melanomas are generally located in
women on the extremities, especially the lower limbs.4,19
In our report, we identified a balanced distribution for
this gender: trunk (28.7%), lower limbs (27.7%) and
head/neck (25.7%). Meanwhile men usually have high-
er incidence of CM on the trunk (34.0%). According to
our data, the most affected site in men was the lower
limbs (40.2%).23,28
Anatomical distribution of CM changes accord-
ing to sun exposure of the population. Distribution
An Bras Dermatol. 2013;88(4):545-53.
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Years
* 95% CI = 95% Confidence interval   ** p < 0,001 (one-way Anova)
Total 57 28.6 142 71.4
Gender
Female 27 26.7 74 73.3 1.00
Male 30 30.9 67 69.1 1.23 0.66-2.27
Age Group (years)
≤ 50 5 22.7 17 77.3 1.00
> 50 50 29.9 117 70.1 1.45 0.51-4.16
Site
Head and neck 12 30.0 28 70.0 1.99 0.78-5.08
Trunk 11 17.7 51 82.3 1.00
Upper Limbs 7 31.8 15 68.2 2.16 0.71-6.56
Lower Limbs 26 38.8 41 61.2 2.94 1.30-6.65
Histological Type
Nodular 39 37.1 66 62.9 4.88 1.61-14.8
Lentigo maligna 2 10.5 17 89.5 0.97 0.16-5.85
Superficial spreading 4 10.8 33 89.2 1.00
Acral lentiginous 6 28.6 15 71.4 3.30 0.81-13.45
Breslow
≤ 1 mm 2 5.1 37 94.9 1.00
> 1 mm 54 37.5 90 62.5 11.1 2.57-47.91
Clark Level
II 4 12.9 27 87.1 1.00
III 3 8.8 31 91.2 0.65 0.13-3.18
IV 25 37.9 41 62.1 4.12 1.29-13.15
V 24 46.2 28 53.8 5.79 1.77-18.89
Tumor-inﬁltrating lymphocytes
Absence 13 41.9 18 58.1 1.00
Presence 43 27.9 111 72.1 0.54 0.24-1.19
Mitotic index
< 6 mitoses/HPF 22 20.9 83 79.1 1.00
≥ 6 mitoses/HPF 30 40.5 44 59.5 2.57 1.33-4.98
Ulceration
Absence 15 20.0 60 80.0 1.00
Presence 41 37.6 68 62.4 2.41 1.21-4.79
Histopathological regression
Absence 45 30.6 102 69.4 1.06 0.47-2.39
Presence 10 29.4 24 70.6 1.00
Category
Metastasis
Presence Absence
n % n %
OR* 95 CI**
TABLE 2: Distribution and features of 199 invasive cutaneous melanomas, according to gender, diagnosed in a 
pathology reference service in Teresina (Piauí), 2000-2010
* Odds Ratio ** 95% Confidence Interval
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Metastatic site n %
Lymph node 114 78.1
Skin and subcutaneous 33 22.6
Lung 10 6.8
Liver 7 4.8
Brain 4 2.7
Bowel 2 1.4
Bone 2 1.4
Adrenal 1 0.7
Parotid 1 0.7
Salivary gland 1 0.7
Cerebellum 1 0.7
TABLE 3: Metastatic sites of 146 melanomas presenting regional and distant metastases diagnosed 
in a reference pathology service in Teresina (Piauí), 2000-2010
São Paulo-SP Criado et al.7 222 1963-1997 - - 39.8% 10.2% 28.4%* 9.7%
Blumenau-SC Naser8 1002 1980-2009 51.6% 37.0% 23.2% 22.8% 58.7% 10.5%
São Paulo-SP Lapa et al.9 115 1985-1987 - 19.8% - - 9.6%* -
Porto Alegre-RS Venegas et al.10 101 1985-1989 - 36.6% - 35.6% - -
Londrina-PR Gon et al.11 303 1990-1999 37.1% 41.1% 23.1% 34.8% 13.4%* 12.9%
Porto Alegre-RS Bakos12 153 - 51.6% - - - - -
Rio de Janeiro-RJ Fernandes et al.13 65 1993-2003 63.0% 12.3% - - - -
São Paulo-SP Ferrari Júnior et al.3 364 1993-2006 33.8% 26.1% 25.4% 20.4% 23.9% 15.7%
Brasília-DF Pinheiro et al.14 32 1994-1999 10.0% 45.0% 19.4% 32.3% 42.3%* 12.9%
Porto Alegre-RS Bakos et al.15 103 1995-1998 61.2% 23.3% - - - -
Passo Fundo-RS Borges et al.16 229 1995-2001 61.6% 25.3% 24.4% 7.9% 47.2% 7.9%
Porto Alegre-RS Ponzio et al.17 167 - 35.3% - - - - -
Florianópolis-SC Weber et al.1 496 1999-2004 60.0% 30.0% - - 45.7% 37.5%
Porto Alegre-RS Bonfá et al.4 328 2000-2005 62.8% 14.6% 27.4% 7.0% 36.9% 26.2%
São Paulo-SP Maia et al.18 190 - 41.1% - - - - -
Florianópolis-SC Dimatos et al.5 105 2003-2007 68.7% 18.2% 19.0% 5.7% 30.4% 39.0%
Criciúma-SC Konrad el al.19 72 2005-2007 50.0% 23.4% 26.1% 0.0% 25.0%* 29.6%
Teresina-PI This study 313 2000-2010 18.6% 52.8% 32.7% 26.1% 19.6% 7.9%
City Author n Years
Histological type Clark level
SS NO IV V
Breslow In situ
≤ 1mm
TABLE 4: Comparison of various Brazilian studies on melanoma
SS: Superfical Spreading Melanoma NO: Nodular Melanoma *≤ 0.75mm
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also changes with age. For example, melanomas in the
chronically sun-exposed areas (face, scalp and neck) are
more common in the elderly than the young.29
Anatomic location of the primary melanoma is an
important independent predictor of sentinel lymph
node status and prognosis. Patients with primary
melanomas of the head/neck and trunk usually have a
worse prognosis than primary melanomas in other
anatomic locations.30
In 109 cases (54.8%) the presence of ulceration
was revealed. This is one of the independent factors
associated with prognosis that is more consolidated in
the literature. It is believed that ulceration develops
due to ischemia secondary to a rapidly growing tumor,
which suggests that it is associated with a worse prog-
nosis.22 Balch et al., in a study of 17,600 patients,
demonstrated that tumor thickness and presence of
ulceration were the most significant predictors of sur-
vival, with a relative risk of 1.558 (1.473-1.647) and
1.901 (1.735-2.083), respectively.31
In our series, the high rate of ulceration was con-
sistent with late diagnosis. In São Paulo (SP),
Florianópolis (SC) and Porto Alegre (RS), the ulceration
rate was 35.1, 23.3 and 24.4% respectively.1,3,4 As
observed at other studies, women presented fewer
ulcerated lesions (51.5% in comparison to 58.8% of
men, but no significant difference). It is possible that
women devote more attention to their own health and
are more likely to seek dermatological advice.3
In 74 cases (37.2%), the mitotic index was greater
than or equal to 6 mitoses / HPF (high-power field).
This proportion was significant higher among men
(46.4% as against 28.7% women). It is suggested that
high mitotic index is also an important prognostic fac-
tor. Azzola et al. investigated 3661 patients with cuta-
neous melanoma, finding that patients with a mitotic
index of 0 mitoses/mm2 presented a 10-year survival
rate of 95%, as compared with 80% in patients with a
mitotic index between 1 and 4 mitoses/mm2, 70% in
those withan index of 5-10 mitoses/mm2 and 60% in
those with 11 or more mitoses.32
Melanoma has the potential to  metastasize
through the lymph nodes to visceral organs. Metastases
most commonly first present at regional lymph nodes,
but around one third of them present directly at distant
sites, with the lungs the main site.1 Considering the 57
cases of invasive CM which presented metastasis and
the 89 cases of metastatic melanoma (a total of 146), the
main sites of regional and distant metastases were the
lymph nodes (78.1%), skin and subcutaneous areas
(22.6%), lung (6.8%) and liver (4.8%) (Table 3). Lymph
nodes, skin and subcutaneous lesions were also found
to be the most common sites by a Brazilian survey car-
ried out in the city of Florianópolis (state of Santa
Catarina).1
Nodular melanoma (OR = 4.88; 95 CI =1.61-14.8),
Clark IV (OR = 4.12, 95 CI = 1.29-13.15), Clark V (OR =
5.79, 95 CI = 1.77-18.89), Breslow > 1 mm (OR = 11.1, 95
CI = 2.57-47.91), mitotic index ≥ 6 (OR = 2.57, 95 CI =
1.33-4.98) and ulcerated lesions (OR = 2.41, 95 CI = 1.21-
4.79) were more likely to metastasize, representing fac-
tors of worst prognosis (Table 2). These were sadly the
predominant features in our sample, revealing a histo-
ry of  late diagnosis and poor prognosis in Teresina.
(Table 1).
Melanoma may present clinically as a metastatic
disease, without evidence of primary cutaneous
involvement. We observed 89 (28.4%) cases of
melanoma of unknown primary site in our series, mar-
ginally higher than the rate observed in Florianópolis
(SC) (20.2%).1 Some theories have set out to explain this
phenomenon: the primary lesion removed surgically
without histopathological study of the material, the pri-
mary site cutaneous melanoma with clinical appear-
ance of benign lesion, the primary lesion located in the
scalp, gastrointestinal tract, adrenals, meninges, retina,
palate, vulva, vagina, anorectal area; primary lesion
with spontaneous regression (hypochromic macula)
due to immunological phenomena.33 In our study, we
had to consider that this rate could well be an overesti-
mate since all the histopathological examinations were
included, and in some cases the patient only took the
resected lesion for study and was not followed up in
our dermatology department.
Over the past few years, with the use of PET-CT
(Positron Emission Tomography-Computed
Tomography), the incidence of melanoma of unknown
primary site has tended to decrease. PET-CT is widely
used in oncology for lesion detection and characteriza-
tion, as well as for accurate lesion localization.
Melanoma cells usually demonstrate a high uptake of
the glucose analog F-fluorodeoxyglucose (FDG) - the
finding that established the rationale for the use of FDG
in melanoma, allowing whole-body tumor detection
and which proved to be useful for detecting primary
tumors.18,34,35 Unfortunately the high cost of this test is a
limiting factor in Brazil.
CONCLUSION
The histopathological profile of melanoma in
our study was the nodular histological type, Breslow
thickness> 1 mm, Clark level IV and V, with the pres-
ence of ulceration and lymphocytic infiltrate in the
tumor and high rates of metastasis. The main factors
associated with metastasis were of the nodular type,
Clark IV / V, Breslow> 1mm, mitotic index ≥ 6 and
ulcerated lesions. ❑
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